43 results on '"Mellado, Emilia"'
Search Results
2. Aspergillus fumigatus Cross-Resistance between Clinical and Demethylase Inhibitor Azole Drugs
3. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in Aspergillus Species Received within a Surveillance Program on Antifungal Resistance in Spain
4. Two KTR Mannosyltransferases Are Responsible for the Biosynthesis of Cell Wall Mannans and Control Polarized Growth in Aspergillus fumigatus
5. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms
6. Fitness Studies of Azole-Resistant Strains of Aspergillus fumigatus
7. Hitting the Caspofungin Salvage Pathway of Human-Pathogenic Fungi with the Novel Lasso Peptide Humidimycin (MDN-0010)
8. Genetic Relatedness versus Biological Compatibility between Aspergillus fumigatus and Related Species
9. Resistance to Voriconazole Due to a G448S Substitution in Aspergillus fumigatus in a Patient with Cerebral Aspergillosis
10. Role of Aspergillus lentulus 14-α Sterol Demethylase (Cyp51A) in Azole Drug Susceptibility
11. Aspergillus Species and Other Molds in Respiratory Samples from Patients with Cystic Fibrosis: a Laboratory-Based Study with Focus on Aspergillus fumigatus Azole Resistance
12. Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
13. Identification of Pathogenic Rare Yeast Species in Clinical Samples: Comparison between Phenotypical and Molecular Methods
14. Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri
15. Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds
16. Susceptibility Testing and Molecular Classification of Paecilomyces spp
17. Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus
18. Aspergillus Section Fumigati : Antifungal Susceptibility Patterns and Sequence-Based Identification
19. Rapid Detection of Triazole Antifungal Resistance in Aspergillus fumigatus
20. In Vitro Activities of 35 Double Combinations of Antifungal Agents against Scedosporium apiospermum and Scedosporium prolificans
21. Time of Incubation for Antifungal Susceptibility Testing of Aspergillus fumigatus : Can MIC Values Be Obtained at 24 Hours?
22. In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis
23. Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi
24. Aspergillus fumigatus C-5 Sterol Desaturases Erg3A and Erg3B: Role in Sterol Biosynthesis and Antifungal Drug Susceptibility
25. In Vitro Activity of Ravuconazole against 923 Clinical Isolates of Nondermatophyte Filamentous Fungi
26. Susceptibility Patterns and Molecular Identification of Trichosporon Species
27. Analysis of the Influence of Tween Concentration, Inoculum Size, Assay Medium, and Reading Time on Susceptibility Testing of Aspergillus spp
28. Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus
29. In Vitro Activities of Ravuconazole and Four Other Antifungal Agents against Fluconazole-Resistant or -Susceptible Clinical Yeast Isolates
30. Genotyping and Antifungal Susceptibility Profile of Dipodascus capitatus Isolates Causing Disseminated Infection in Seven Hematological Patients of a Tertiary Hospital
31. G484S Amino Acid Substitution in Lanosterol 14-α Demethylase ( ERG11 ) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate
32. In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp
33. Scopulariopsis brevicaulis , a Fungal Pathogen Resistant to Broad-Spectrum Antifungal Agents
34. VI. THERAPY: Chapter 34: Antifungal Mechanisms of Action and Resistance.
35. VI: Evolutionary Pathogenicity of Pathogenic Fungi: Chapter 49: Aspergillus as a Human Pathogen: an Evolutionary Perspective.
36. Comparative Evaluation of NCCLS M27-A and EUCAST Broth Microdilution Procedures for Antifungal Susceptibility Testing of Candida Species
37. Detection of Resistance to Amphotericin B in Candida Isolates by Using Iso-Sensitest Broth
38. Standardization of Antifungal Susceptibility Variables for a Semiautomated Methodology
39. Azasordarins: Susceptibility of Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida spp. to GW 471558
40. Inoculum Standardization for Antifungal Susceptibility Testing of Filamentous Fungi Pathogenic for Humans
41. Influence of Glucose Supplementation and Inoculum Size on Growth Kinetics and Antifungal Susceptibility Testing of Candida spp
42. Genetic Similarity among One Aspergillus flavus Strain Isolated from a Patient Who Underwent Heart Surgery and Two Environmental Strains Obtained from the Operating Room
43. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.